Overseas Chinese Equities, Aequitas Research

Ming Lu

Overseas Chinese Equities

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Bottom-Up

<ul>
<li>The revenue growth rate decelerated, but operating loss shrank in 2Q22.</li>
<li>We believe the the revenue reclassification is unnecessary and suspicious.</li>
<li>We set a downside of 19% and a price target of HK$148.</li>
</ul>


The revenue growth rate decelerated, but operating loss shrank in 2Q22.
We believe the the revenue reclassification is unnecessary and suspicious.
We set a downside of 19% and a price target of HK$148.


Meituan (3690 HK): 2Q22, Reduced Loss, But Unnecessarily Reclassifies Revenue

Head of Research, IPOs & Placements, Aequitas Research

Sumeet Singh

Head of Research, IPOs & Placements

Event-Driven

<ul>
<li>On 26th Aug 2022, PCAOB and CSRC announced that they had entered into an agreement granting US authorities access to investigate public accounting firms headquartered in China and HK.</li>
<li>On 2nd Apr 2022, CSRC put out a draft for public comments on the revision of certain provisions which would allow easier access by overseas regulators to China ADRs audits.</li>
<li>In this note, we'll talk about the latest developments and its implications.</li>
</ul>


On 26th Aug 2022, PCAOB and CSRC announced that they had entered into an agreement granting US authorities access to investigate public accounting firms headquartered in China and HK.
On 2nd Apr 2022, CSRC put out a draft for public comments on the revision of certain provisions which would allow easier access by overseas regulators to China ADRs audits.
In this note, we'll talk about the latest developments and its implications.


China ADRs Delisting - Tide Is Turning - Non-HK Listed ADRs Are Already Outperforming

Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

Asia Pac IPO & Placement Research, China biotech

Quantitative Analysis

<ul>
<li>We analyze the weekly Hong Kong Connect flows with our data engine for holding position as of August 26th.</li>
<li>The top stocks by inflows and outflows were tabulated for all market, HSCEI, mid cap and s/mid cap groups.</li>
<li>We highlight flows for CNOOC, Meituan and Hong Kong Exchange.</li>
</ul>


We analyze the weekly Hong Kong Connect flows with our data engine for holding position as of August 26th.
The top stocks by inflows and outflows were tabulated for all market, HSCEI, mid cap and s/mid cap groups.
We highlight flows for CNOOC, Meituan and Hong Kong Exchange.


Hong Kong Connect Flows: Meituan Outflows Before 1H Results

<ul>
<li>We analyzed the latest HK SFC report for aggregate short position as of Aug 19th. </li>
<li>Top short increases and decreases were tabulated for one week and four week period. </li>
<li>We highlight short interest changes in China Power Intl, HKEx, CLP, Geely, JD.com, ENN Energy.</li>
</ul>


We analyzed the latest HK SFC report for aggregate short position as of Aug 19th. 
Top short increases and decreases were tabulated for one week and four week period. 
We highlight short interest changes in China Power Intl, HKEx, CLP, Geely, JD.com, ENN Energy.


HK Short Interest: China Power Intl, HKEx, CLP, Geely

Equity Capital Markets

China Tourism Group Duty Free / Equity Capital Markets

<ul>
<li>Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.</li>
<li>On the IPO front, China Tourism's listing appears to have set the ball rolling for others to follow.</li>
<li>After a flurry of activity in the prior week, there weren't any major placements this week.</li>
</ul>


Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
On the IPO front, China Tourism's listing appears to have set the ball rolling for others to follow.
After a flurry of activity in the prior week, there weren't any major placements this week.


ECM Weekly (28th Aug 2022) - China Tourism, BA REIT, Hongjiu Fruit, YH Ent, Biocyto, WM, APM, Daiwa

China

Meituan operates as a web based shopping platform for locally found consumer products and retail services. The Company offers deals of the day by selling vouchers on local services and entertainment, dining, delivery, and other services. Meituan provides its services throughout China.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Meituan (3690 HK)

Meituan (3690 HK): 2Q22, Reduced Loss, But Unnecessarily Reclassifies Revenue

The revenue growth rate declined due to the lockdown in big cities. The operating loss shrank, because Meituan cut marketing expenses. We set a...

Ming Lu

China ADRs Delisting - Tide Is Turning - Non-HK Listed ADRs Are Already Outperforming

On 26th Aug 2022, PCAOB and CSRC announced that they had entered into an agreement granting US authorities access to investigate public accounting...

Sumeet Singh

Hong Kong Connect Flows: Meituan Outflows Before 1H Results

We highlight Hong Kong Connect southbound weekly flows for CNOOC, Meituan and Hong Kong Exchange for the week ended on August 26th.

Ke Yan, CFA, FRM

HK Short Interest: China Power Intl, HKEx, CLP, Geely

We highlight short interest changes in China Power Intl, HKEx, CLP, Geely, JD.com, ENN Energy based on latest Hong Kong SFC short aggregate report.

Ke Yan, CFA, FRM

ECM Weekly (28th Aug 2022) - China Tourism, BA REIT, Hongjiu Fruit, YH Ent, Biocyto, WM, APM, Daiwa

Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.

Sumeet Singh

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)